Circulating Tumor DNA (ctDNA) Dynamics Predict Early Response to Treatment in Metastasized Gastroesophageal Cancer (mGEC) After 2 Weeks of Systemic Treatment
ctDNA is a promising additional biomarker allowing for early evaluation of response to treatment and saving unevaluated treatment time for patients with mGEC, and could allow for an early change in treatment with anticipated prognostic benefit in the future.
Authors
- Bernhard Doleschal (ORCID: https://orcid.org/0009-0004-4813-4435)
- Gerald Webersinke (ORCID: https://orcid.org/0000-0001-5654-6190)
- Emina Jukic (ORCID: https://orcid.org/0000-0001-6909-7005)
- Matthias Biebl (ORCID: https://orcid.org/0000-0002-3690-8614)
- Lukas Havranek (ORCID: https://orcid.org/0000-0002-7656-1862)
- Alexander Kupferthaler (ORCID: https://orcid.org/0000-0002-3429-2203)
- Holger F. Rumpold (ORCID: https://orcid.org/0000-0002-4118-0111)
- Daniel Rezaie
- Johannes Zschocke (ORCID: https://orcid.org/0000-0002-0046-8274)
- Patrick Kirchweger (ORCID: https://orcid.org/0000-0003-2806-4594)
- S Tatalović (ORCID: https://orcid.org/0009-0004-4419-1723)
- Simon Schwendinger (ORCID: https://orcid.org/0000-0002-7542-222X)
- Jonathan Burghofer (ORCID: https://orcid.org/0000-0001-6720-4671)
- L. Danhel
- Antonia Kirchweger
- Demetre Shalamberidze
- Stephan Grundner
Institutions
- Johannes Kepler University of Linz (AT)
- Innsbruck Medical University (AT)
Publication Details
- Journal
- Cancers
- Published
- 2024-11-26
- DOI
- https://doi.org/10.3390/cancers16233960
- Citations
- 3
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.86